Comprehensive analysis of biomarkers for prostate cancer based on ...

Prostate cancer (PCa) is one of the leading causes of cancer-related death. In the present research, we adopted a comprehensive bioinformatics ...

Abstract. Background: Prostate cancer (PCa) is one of the leading causes of cancer-related death. In the present research, we adopted a comprehensive ...

Comprehensive analysis of biomarkers for prostate cancer...

Prostate cancer (PCa) is one of the leading causes of cancer-related death. In the present research, we adopted a comprehensive bioinformatics method to ...

Comprehensive analysis of biomarkers for prostate cancer based on ...

... Weighted gene co-expression network analysis (WGCNA) is an algorithm that construct free-scale gene co-expression networks to explore the relationships ...

Liquid Biomarkers in Prostate Cancer Diagnosis

This review critically evaluates the role of liquid biopsy techniques, focusing on blood- and urine-based biomarkers, in overcoming the limitations of ...

Prostate cancer biomarkers: Are we hitting the mark? - ScienceDirect

A growing number of novel biomarkers are currently under investigation. Such markers include urinary biomarkers, serology-based markers or pathological tissue ...

Advances in Prostate Cancer Biomarkers and Probes

Early diagnosis of PCa is essential to improve the survival rate of patients. However, the occurrence and development of PCa is a complex biological process, ...

Biomarkers for Prostate Cancer: Present Challenges and Future ...

The most common current screening test for PCa is a measurement of the serum concentration of prostate-specific antigen (PSA), which currently cannot reliably ...

Protein Biomarkers and Multi-analyte Biomarker Tests for Screening ...

Prostate cancer is a complex, heterogeneous disease. At the extremes of the spectrum, if left untreated, some prostate cancers behave aggressively, metastasize ...

Current and emerging tissue‐based molecular biomarkers for ...

The full kallikrein panel was found to enhance the predictive accuracy for clinically diagnosed prostate cancer. They concluded that men with a ...

Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline

Numerous tissue-based molecular biomarkers were evaluated for their prognostic capabilities and potential for improving management decisions.

Novel diagnostic biomarkers for prostate cancer

Biomarkers are widely used as analytical tools to assess biological parameters for a rapid and comprehensive therapeutic analysis. In addition, biomarker ...

understanding prostate cancer pathology and protein biomarkers for ...

Although PSA remains the gold-standard biomarker for PCa diagnosis and is one of the most widely used blood-based biomarkers in cancer, it ...

A comprehensive analysis of ncRNA-mediated interactions reveals ...

As one of common malignancies, prostate adenocarcinoma (PRAD) has been a growing health problem and a leading cause of cancer-related death. To obtain ...

Blood-based and urinary prostate cancer biomarkers - Nature

The diagnosis of prostate cancer (PCa) is currently based on serum PSA testing and/or abnormal digital rectal examination and ...

Prostate Cancer Biomarker Development: National Cancer Institute's ...

1). Diagnosis of prostate cancer is initiated through screening and confirmed through subsequent biopsy. This is a critical junction for decision-making and an ...

Biomarkers for detection of clinically significant prostate cancer

The Beckman Coulter PHI is a blood-based assay that combines [-2] proPSA (p2PSA), free PSA (fPSA), and total PSA (tPSA) into a single score to predict ...

Identification and validation of diagnostic and prognostic biomarkers ...

Prostate cancer (PCa) represents a significant health challenge for men, and the advancement of the disease often results in a grave ...

Validation of potential RNA biomarkers for prostate cancer diagnosis ...

Two mRNA biomarkers—GLO1 and NKX3-1 showed promising diagnostic potential in distinguishing between PCa and BPH with AUC of 0.68 and 0.82, ...

Biomarkers for Prostate Cancer: From Diagnosis to Treatment - MDPI

Based on miRNA research, a ratio analysis was employed to enhance the diagnostic accuracy. The urinary miR-1913 to miR-3659 ratio was found to be elevated in ...